251 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
INCY Incyte Corporation $67.04 $14.25B N/A
Article Searches
Incyte (INCY) Up 5.2% Since Earnings Report: Can It Continue? http://www.zacks.com/stock/news/296008/incyte-incy-up-52-since-earnings-report-can-it-continue?cid=CS-ZC-FT-296008 Mar 19, 2018 - Incyte (INCY) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Is Geron Corporation's Stock Set to Sail or Sink? https://www.fool.com/investing/2018/03/18/is-geron-corporations-stock-set-to-sail-or-sink.aspx?source=iedfolrf0000001 Mar 18, 2018 - Geron's fourth-quarter earnings release raises more questions than it answers.
AstraZeneca's Final Data From Key Lung Cancer Study Delayed http://www.zacks.com/stock/news/295477/astrazenecas-final-data-from-key-lung-cancer-study-delayed?cid=CS-ZC-FT-295477 Mar 13, 2018 - AstraZeneca's (AZN) final overall survival data from the pivotal phase III MYSTIC study on Imfinzi in first line lung cancer to be delayed in the second half of 2018.
The Zacks Analyst Blog Highlights: Royal Dutch, Mastercard, Itau Unibanco, Suncor and Incyte http://www.zacks.com/stock/news/295028/the-zacks-analyst-blog-highlights-royal-dutch-mastercard-itau-unibanco-suncor-and-incyte?cid=CS-ZC-FT-295028 Mar 09, 2018 - The Zacks Analyst Blog Highlights: Royal Dutch, Mastercard, Itau Unibanco, Suncor and Incyte
Top Analyst Reports for Royal Dutch Shell, Mastercard & Itau Unibanco http://www.zacks.com/research-daily/152377/top-analyst-reports-for-royal-dutch-shell-mastercard-itau-unibanco?cid=CS-ZC-FT-152377 Mar 08, 2018 - Top Analyst Reports for Royal Dutch Shell, Mastercard & Itau Unibanco
M&A, Innovation & New Drugs to Drive Pharma Stocks http://www.zacks.com/commentary/152408/ma-innovation-new-drugs-to-drive-pharma-stocks?cid=CS-ZC--152408 Mar 08, 2018 - M&A, Innovation & New Drugs to Drive Pharma Stocks
Stocks Take the Powell Plunge https://www.zacks.com/registration/ultimatetrader/welcome/eoffer/30c3?adid=ZU_CONTENT_SYND&cid=CS-ZC-FT-1607 Feb 28, 2018 - Stocks Take the Powell Plunge
Biotech Stock Round Up: Celgene Suffers Setback, Gilead Teams Up with Sangamo http://www.zacks.com/stock/news/294104/biotech-stock-round-up-celgene-suffers-setback-gilead-teams-up-with-sangamo?cid=CS-ZC-FT-294104 Feb 28, 2018 - The major news in the biotech sector in the last five trading sessions include the FDA's refusal to file letter for Celgene Corporation's (CELG) ozanimod while Gilead Sciences, Inc.'s (GILD) announced an agreement with Sangamo Therapeutics.
Zacks.com featured highlights include: Incyte, Altice USA, Archrock, Live Nation and PTC http://www.zacks.com/stock/news/293094/zackscom-featured-highlights-include-incyte-altice-usa-archrock-live-nation-and-ptc?cid=CS-ZC-FT-293094 Feb 21, 2018 - Zacks.com featured highlights include: Incyte, Altice USA, Archrock, Live Nation and PTC
Incyte (INCY) Q4 2017 Earnings Conference Call Transcript https://www.fool.com/earnings/call-transcripts/2018/02/20/incyte-incy-q4-2017-earnings-conference-call-trans.aspx?source=iedfolrf0000001 Feb 20, 2018 - INCY earnings call for the period ending December 31, 2017.

Pages: 1...7891011121314151617...26

<<<Page 12>